Healthcare Market Research Reports

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 24 Dec 2020  |  Global  |  Technology Research

    Emerging Neuromodulation Technologies Enabling Growth Opportunities in Mental Health Care

    Breakthrough Innovations in Transcranial Electrical Stimulation, Transcranial Magnetic Stimulation, Cranial Electrotherapy Stimulation and other Non-invasive Neuromodulation Therapies Bolstering the Psychiatric Toolbox

    The treatment of mental health disorders using pharmaceuticals and psychotherapy are plagued with limitations such as therapy-related adverse effects, and inability to provide effective remission. This has driven the use of neuromodulation techniques for managing these conditions. However, these traditional neuromodulation therapies have their shar...

    $4,950.00
  2. 23 Dec 2020  |  North America  |  Frost Radar

    Frost Radar™: US Healthcare Cybersecurity Market, 2020

    A Benchmarking System to Spark Companies to Action—Innovation That Fuels New Deal Flow and Growth Pipelines

    The US healthcare cybersecurity market is poised for aggressive growth after the COVID-19 pandemic ends. The impending challenges related to the top 5 cyber threats (phishing attacks, credential harvesting, ransomware, social engineering attacks, and information theft or loss) will drive a higher spend on progressive cybersecurity solutions across...

    $4,950.00
  3. 22 Dec 2020  |  Global  |  Frost Radar

    Frost Radar™: Global Endoscopy Market, 2020

    A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

    Globally, the demand for minimally invasive surgeries is trending upward at a quick pace, so consequently the demand for innovative endoscopy devices used in these procedures is anticipated to surge in the mid-to-long term. Moreover, health systems will be forced to clear the backlogs of “elective surgeries” that were postponed due to the COVID...

    $4,950.00
  4. 15 Dec 2020  |  Global  |  Frost Radar

    Frost Radar™: Advanced Antibodies, 2020

    A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

    With advances in antibody-based therapies, bispecific antibodies (bsAbs) have gained momentum in the last few years after the regulatory approvals of Amgens blinatumomab (Blincyto®) and Chugais Hemlibra for Hemophilia A. The key advantage of bsAbs lies in their ability to bind two different epitopes or antigens, thereby overcoming the limitations ...

    $4,950.00
  5. 15 Dec 2020  |  North America  |  Technology Research

    Technology Breakthroughs and Growth Opportunity in Digital Dentistry

    Leveraging digital solutions for transforming the quality and efficiency of dental practices

    This research service explores the various technology breakthroughs transforming dentistry and the growth opportunities of the digital dental solutions. The report also provides strategic recommendations to capitalize on the growing market. Digital dentistry, the use of digital or computer-controlled dental technologies or devices for dental proced...

    $4,950.00
  6. 09 Dec 2020  |  Global  |  Frost Radar

    Frost Radar™: Microbiome Therapeutics, 2020

    A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

    Microbiome present in the human body has a major role to play in the overall functioning of the human body. Human microbiota consists of a diverse population of bacterial, viral and eukaryotic communities and is present on skin, nasopharynx, oral cavity, respiratory tract, gastrointestinal tract and female reproductive tract. The naturally occurri...

    $4,950.00
  7. 04 Dec 2020  |  Global  |  Frost Radar

    Frost Radar™: Digital Biomarkers Through Connected Devices, 2020

    A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

    High prevalence of complex diseases, high investments and low success rate associated with drug development, are making the health industry appeal for innovative technologies that can enhance understanding of complex diseases, contribute to the development of personalized treatments, accelerate clinical trial activities, and lower the R&D expenditu...

    $4,950.00
  8. 30 Nov 2020  |  North America  |  Frost Radar

    Frost Radar™: Intelligent Imaging Analysis Systems, 2020

    A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

    Healthcare facilities across the globe have been facing twin challenges in terms of rising patient imaging volumes attributed to the growing prevalence of chronic diseases and acute shortage of radiologists and clinicians required to review them. The current practice of manual viewing and grading of the medical images by the radiologists and clinic...

    $4,950.00
  9. 30 Nov 2020  |  Global  |  Technology Research

    Analysing Sepsis Management Part II: Treatments

    Recent developments in Sepsis Treatment focused towards antibiotics, inhibitors, antibodies, peptides, recombinant proteins, antibacterial, antifungal, antivirals, vaccines, and probiotics

    Sepsis is a life-threatening condition caused by overactivation of host immune system upon infections which may lead to organ failure and potentially death. World Health Organization designates sepsis as a global public health priority. Several studies conducted to understand the molecular basis of sepsis, septic shock, and organ failure. Despite e...

    $4,950.00
  10. 03 Nov 2020  |  North America  |  Frost Radar

    Frost Radar™: Global Full Product Development CMO in the IVD Industry, 2020

    A Benchmarking System to Spark Companies to Action—Innovation That Fuels New Deal Flow and Growth Pipelines

    Full product development IVD CMO comprises companies that partner with OEMs and support them in the development of IVD devices, ranging from concept to commercialization. IVD companies are continuously looking at new ways to optimize resources due to rising cost pressures and regulatory complexities, prompting industry participants to adopt innovat...

    $4,950.00